Westminster is buzzing. A quiet word in the Lobby suggests the science minister is about to make a splash. The news: a British team at Porton Down has cracked it. An Ebola vaccine. Human trials within months.
This is big. Not just for global health. For the government's credibility on science. After years of Brexit uncertainty, a win. A British-led breakthrough. The PM's 'Global Britain' narrative gets a shot in the arm.
Sources say the jab uses a new platform. Faster to produce. Easier to store. The sort of thing that would have saved thousands in West Africa in 2014. The WHO is watching. So is Downing Street.
But the game is never simple. The science minister, a rising star, is eyeing a promotion. This vaccine is his ticket. He needs it to work. Fast. The Treasury is already signing cheques. Emergency funding. No questions asked. That tells you everything about the political stakes.
Inside the Lobby, the talk is of 'cautious optimism'. But the real vibe is 'finally'. A win for UK science. A win for the government. A win for the minister. And if it works in humans, a win for the world. But politics is a nasty business. One bad side effect in trials and the whole thing unravels. The opposition is sharpening their knives. They want 'transparency'. They want 'safety assurances'. They smell blood if this goes wrong.
For now, the government is playing it cool. A press conference later today. The science minister will be flanked by researchers. The message: 'Britain leads the world'. Expect plenty of flag-waving. Expect the usual platitudes about 'working with international partners'. But this is all about domestic politics. The vaccine is a shield. It protects the PM from attacks on his handling of the pandemic. It protects the science brief from being cut in the next spending review.
I suspect the trials will be fast-tracked. Red tape slashed. The MHRA is under pressure to approve quickly. That will cause its own headaches. Safety versus speed. The classic dilemma. The Hodge committee is already demanding to see the data. They will get it, eventually. But the government will control the narrative.
Watch the backbenches. The usual suspects are stirring. They want to know who is getting the profits. A Big Pharma angle. The vaccine is developed with a small British biotech firm. That's clever. Keeps it at arm's length from the big boys. But the funding is public. Taxpayers' money. There will be questions about intellectual property. About 'fair pricing'. The minister will have to answer. His answer? 'Affordable access'. We shall see.
Bottom line: This is a huge political gamble. If it pays off, the PM gets a talisman. 'We delivered a British vaccine for Ebola.' If it fails, the recriminations will be brutal. But for now, the mood in Downing Street is buoyant. They are preparing a victory lap. But in politics, victory is never certain. One leak, one adverse event, and the narrative shifts. I'll be watching the data. And the whispers.
More to follow. This story is moving fast.
